Clariene SE [CLARI] vs Orpea [ORP] Detailed Stock Comparison
TLDR: Quick Comparison Summary
Based on 18 vital metrics comparison: Clariene SE wins in 4 metrics, Orpea wins in 9 metrics, with 0 ties. Orpea appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Clariene SE | Orpea | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 9.76 | 0.10 | Orpea |
| Price-to-Book Ratio | 0.38 | N/A | N/A |
| Debt-to-Equity Ratio | 200.13 | 4.85 | Orpea |
| PEG Ratio | 11.35 | N/A | N/A |
| EV/EBITDA | 10.22 | 3.01 | Orpea |
| Profit Margin (TTM) | 0.03% | 79.36% | Orpea |
| Operating Margin (TTM) | 13.87% | 38.13% | Orpea |
| EBITDA Margin (TTM) | 13.87% | 38.13% | Orpea |
| Return on Equity | 0.23% | 71.75% | Orpea |
| Return on Assets (TTM) | 2.09% | 9.74% | Orpea |
| Free Cash Flow (TTM) | $815.92M | $225.10M | Clariene SE |
| 1-Year Return | 22.87% | 20.26% | Clariene SE |
| Price-to-Sales Ratio (TTM) | 0.26 | 0.42 | Clariene SE |
| Enterprise Value | $8.63B | $10.71B | Orpea |
| EV/Revenue Ratio | 1.63 | 2.06 | Clariene SE |
| Revenue per Share (TTM) | $15 | N/A | N/A |
| Earnings per Share (Diluted) | $0.00 | N/A | N/A |
| Beta (Stock Volatility) | 0.76 | N/A | N/A |
Clariene SE vs Orpea Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Clariene SE | -0.50% | -4.51% | 1.01% | 14.53% | 14.53% | 14.53% |
| Orpea | -1.89% | -4.09% | -0.83% | 11.02% | 11.02% | 11.02% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Clariene SE | 22.87% | 22.87% | 22.87% | 22.87% | 22.87% | 22.87% |
| Orpea | 20.26% | 20.26% | 20.26% | 20.26% | 20.26% | 20.26% |
Performance & Financial Health Analysis: Clariene SE vs Orpea
| Metric | CLARI | ORP |
|---|---|---|
| Market Information | ||
| Market Cap | €1.36B | €2.19B |
| Market Cap Category | Large cap | Large cap |
| 10 Day Avg. Volume | 261,803 | 234,022 |
| 90 Day Avg. Volume | 416,194 | 283,422 |
| Last Close | €4.00 | €14.03 |
| 52 Week Range | €3.27 - €5.51 | €9.94 - €16.19 |
| % from 52W High | -27.38% | -13.34% |
| All-Time High | €7.80 (Jun 12, 2023) | €8,238.46 (Feb 17, 2020) |
| % from All-Time High | -48.72% | -99.83% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.00% | N/A |
| Quarterly Earnings Growth | N/A | N/A |
| Financial Health | ||
| Profit Margin (TTM) | 0.00% | 0.79% |
| Operating Margin (TTM) | 0.14% | 0.38% |
| Return on Equity (TTM) | 0.00% | 0.72% |
| Debt to Equity (MRQ) | 200.13 | 4.85 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | €10.14 | N/A |
| Cash per Share (MRQ) | €2.32 | N/A |
| Operating Cash Flow (TTM) | €1.07B | €-467,871,000 |
| Levered Free Cash Flow (TTM) | €781.67M | €1.35B |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | N/A |
| Last 12-Month Dividend | €0.00 | €0.00 |
Valuation & Enterprise Metrics Analysis: Clariene SE vs Orpea
| Metric | CLARI (Apr 24, 2026) | ORP (Apr 11, 2026) |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 9.76 | 0.10 |
| Forward P/E | 11.35 | 41.04 |
| PEG Ratio | 11.35 | N/A |
| Price to Sales (TTM) | 0.26 | 0.42 |
| Price to Book (MRQ) | 0.38 | N/A |
| Market Capitalization | ||
| Market Capitalization | €1.36B | €2.19B |
| Enterprise Value | €8.63B | €10.71B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 1.63 | 2.06 |
| Enterprise to EBITDA | 10.22 | 3.01 |
| Risk & Other Metrics | ||
| Beta | 0.76 | N/A |
| Book Value per Share (MRQ) | €10.14 | N/A |
Financial Statements Comparison: Clariene SE vs Orpea
Financial Metrics
Loading Financial Charts...
Revenue
Operating Margin
Profit Margin
Long Term Debt
Income Flow Analysis
Financial Statements Comparison
Income Statement
| Metric | CLARI (2025) | ORP (2023) |
|---|---|---|
| Revenue/Sales | 5.31B | 5.20B |
| Cost of Goods Sold | 419.17M | 1.07B |
| COGS % of Revenue | 7.9% | 20.6% |
| Gross Profit | 4.89B | 4.13B |
| Gross Margin | 92.1% | 79.4% |
| Research & Development | N/A | N/A |
| Operating Income (EBIT) | 283.85M | -120.68M |
| Operating Margin | 5.3% | -2.3% |
| EBITDA | 1.12B | 3.56B |
| EBITDA Margin | 21.0% | 68.4% |
| Pre-Tax Income | 11.89M | 1.40B |
| Pre-Tax Income % of Revenue | 0.2% | 26.9% |
| Income Tax | -3.32M | 44.60M |
| Income Tax % of Revenue | -0.1% | 0.9% |
| Net Income (Profit) | 9.20M | 1.36B |
| Profit Margin | 0.2% | 26.2% |
Balance Sheet & Liquidity Metrics
| Metric | CLARI (2025) | ORP (2023) |
|---|---|---|
| Cash & Equivalents | 784.79M | 644.95M |
| Total Current Assets | 1.73B | 2.37B |
| Total Current Assets % of Revenue | 32.6% | 45.6% |
| Total Current Liabilities | 2.43B | 3.12B |
| Total Current Liabilities % of Revenue | 45.8% | 60.0% |
| Long-Term Debt | 6.78B | 7.86B |
| Long-Term Debt % of Revenue | 127.6% | 151.1% |
| Total Shareholders Equity | 3.90B | 1.89B |
| Retained Earnings | N/A | 1.35B |
| Retained Earnings % of Revenue | 0.0% | 26.1% |
| Property, Plant & Equipment | 1.96B | 11.30B |
Cash Flow Statement Comparison
| Metric | CLARI (2025) | ORP (2023) |
|---|---|---|
| Operating Cash Flow | 396.73M | -467.87M |
| Operating Cash Flow % of Revenue | 7.5% | -9.0% |
| Capital Expenditures | -256.28M | -141.04M |
| Free Cash Flow | 815.92M | 225.10M |
| FCF Margin | 15.4% | 4.3% |
| Debt Repayment | -1.08B | -971.97M |
| Common Stock Repurchase | N/A | N/A |
Short Interest & Institutional Ownership Analysis
| Metric | CLARI | ORP |
|---|---|---|
| Shares Short | N/A | N/A |
| Short Ratio | N/A | N/A |
| Short % of Float | N/A | N/A |
| Shares Outstanding | 356.50M | 159.12M |
| Float Shares | 336.56M | N/A |
| % Held by Insiders | 30.77% | N/A |
| % Held by Institutions | 45.17% | N/A |
| % Held by Public | 24.06% | N/A |
Dividend Analysis & Yield Comparison: Clariene SE vs Orpea
| Metric | CLARI | ORP |
|---|---|---|
| Last 12-Month Dividend | €0.00 | €0.00 |
| Last 12-Month Dividend Yield | N/A | N/A |
| 3-Year Avg Annual Dividend | €0.08 | €0.00 |
| 3-Year Avg Dividend Yield | 3.80% | N/A |
| 3-Year Total Dividends | €0.25 | €0.00 |
| Ex-Dividend Date | Jun 21, 2023 | N/A |